Amoy Diagnostics Co., Ltd. operates within the biotechnology industry, specializing in the development and production of molecular diagnostic products. The primary function of the company is to provide advanced diagnostic solutions that leverage its expertise in genetic testing and personalized medicine. Amoy Diagnostics is renowned for its innovative approach to cancer detection, offering cancer companion diagnostics that are pivotal in guiding targeted therapy decisions. These diagnostic solutions are highly significant within the healthcare sector, impacting treatment regimes and improving patient outcomes by enabling more accurate and earlier detection of diseases.

The company's offerings are critical in various medical fields, including oncology, infectious diseases, and genetic disorders, positioning Amoy Diagnostics as a key contributor to the advancement of precision medicine. Its market role extends to enhancing clinical decision-making and contributing to the rising trend of tailored patient care solutions. Headquartered in China, Amoy Diagnostics holds a strong presence domestically and is expanding its influence internationally, marking its significance in the global biotechnology and healthcare markets.